<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(10)</volume><submitter>Cazzato G</submitter><pubmed_abstract>Over the years, increasing information has been asked of the pathologist: we have moved from a purely morphological diagnosis to biomolecular and genetic studies, which have made it possible to implement the use of molecular targeted therapies, such as anti-epidermal growth factor receptor (EGFR) molecules in EGFR-mutated lung cancer, for example. Today, next generation sequencing (NGS) has changed the approach to neoplasms, to the extent that, in a short time, it has gained a place of absolute importance and diagnostic, prognostic and therapeutic utility. In this scenario, formaldehyde-fixed and paraffin-embedded (FFPE) biological tissue samples are a source of clinical and molecular information. However, problems can arise in the genetic material (DNA and RNA) for use in NGS due to fixat</pubmed_abstract><journal>Genes</journal><pagination>1472</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8535326</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Formalin-Fixed and Paraffin-Embedded Samples for Next Generation Sequencing: Problems and Solutions.</pubmed_title><pmcid>PMC8535326</pmcid><pubmed_authors>Cimmino A</pubmed_authors><pubmed_authors>Romita P</pubmed_authors><pubmed_authors>Foti C</pubmed_authors><pubmed_authors>Venerito V</pubmed_authors><pubmed_authors>Cormio G</pubmed_authors><pubmed_authors>Maiorano E</pubmed_authors><pubmed_authors>Cazzato G</pubmed_authors><pubmed_authors>Caporusso C</pubmed_authors><pubmed_authors>Rossi R</pubmed_authors><pubmed_authors>De Marco A</pubmed_authors><pubmed_authors>Colagrande A</pubmed_authors><pubmed_authors>Loizzi V</pubmed_authors><pubmed_authors>Parente P</pubmed_authors><pubmed_authors>Ingravallo G</pubmed_authors><pubmed_authors>Scarcella VS</pubmed_authors><pubmed_authors>Lettini T</pubmed_authors><pubmed_authors>Stellacci A</pubmed_authors><pubmed_authors>Marrone M</pubmed_authors><pubmed_authors>Resta L</pubmed_authors><pubmed_authors>Tarantino P</pubmed_authors><pubmed_authors>Arezzo F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Formalin-Fixed and Paraffin-Embedded Samples for Next Generation Sequencing: Problems and Solutions.</name><description>Over the years, increasing information has been asked of the pathologist: we have moved from a purely morphological diagnosis to biomolecular and genetic studies, which have made it possible to implement the use of molecular targeted therapies, such as anti-epidermal growth factor receptor (EGFR) molecules in EGFR-mutated lung cancer, for example. Today, next generation sequencing (NGS) has changed the approach to neoplasms, to the extent that, in a short time, it has gained a place of absolute importance and diagnostic, prognostic and therapeutic utility. In this scenario, formaldehyde-fixed and paraffin-embedded (FFPE) biological tissue samples are a source of clinical and molecular information. However, problems can arise in the genetic material (DNA and RNA) for use in NGS due to fixat</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-21T14:51:17.062Z</modification><creation>2025-04-21T14:51:17.062Z</creation></dates><accession>S-EPMC8535326</accession><cross_references><pubmed>34680867</pubmed><doi>10.3390/genes12101472</doi></cross_references></HashMap>